AGVDX
Price
$26.64
Change
+$0.17 (+0.64%)
Updated
Sep 4 closing price
Net Assets
18.05B
RWIBX
Price
$71.65
Change
+$0.52 (+0.73%)
Updated
Sep 4 closing price
Net Assets
136.94B
Interact to see
Advertisement

AGVDX vs RWIBX

Header iconAGVDX vs RWIBX Comparison
Open Charts AGVDX vs RWIBXBanner chart's image
American Funds Global Insight C
Price$26.64
Change+$0.17 (+0.64%)
VolumeN/A
Net Assets18.05B
American Funds Capital World Gr&Inc R2
Price$71.65
Change+$0.52 (+0.73%)
VolumeN/A
Net Assets136.94B
AGVDX vs RWIBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AGVDX vs. RWIBX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGVDX is a StrongBuy and RWIBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 137B vs. AGVDX (18.1B). RWIBX pays higher dividends than AGVDX: RWIBX (0.80) vs AGVDX (0.17). AGVDX was incepted earlier than RWIBX: AGVDX (6 years) vs RWIBX (23 years). AGVDX (1.56) and RWIBX (1.51) have similar cost to investors . RWIBX is a more actively managed with annual turnover of: 27.00 vs. AGVDX (21.00). AGVDX (250) and RWIBX (250) have matching initial minimum investment requirements. AGVDX annual gain was more profitable for investors over the last year : 14.60 vs. RWIBX (11.27). AGVDX return over 5 years is better than : 55.66 vs. RWIBX (42.43).
AGVDXRWIBXAGVDX / RWIBX
Total Expense Ratio1.561.51103%
Annual Report Gross Expense Ratio1.561.51103%
Fund Existence6 years23 years-
Gain YTD15.07615.071100%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets18.1B137B13%
Annual Yield % from dividends0.170.8021%
Returns for 1 year14.6011.27129%
Returns for 3 years53.5949.82108%
Returns for 5 years55.6642.43131%
Returns for 10 yearsN/A73.59-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRNA24.280.23
+0.96%
Moderna
YMAB8.57-0.01
-0.12%
Y-mAbs Therapeutics
COGT12.94-0.14
-1.07%
Cogent Biosciences
WVVIP3.21-0.05
-1.44%
Willamette Valley Vineyards
PRLD1.14-0.08
-6.56%
Prelude Therapeutics